Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Buy
63
DRUG.CX Quote, Financials, Valuation and Earnings
Last price:
$116.00
Seasonality move
:
-25.59%
Day range:
$112.44 - $116.00
52-week range:
$33.01 - $131.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
15.80x
Volume:
800
Avg. volume:
1.4K
1-year change:
109.44%
Market cap:
$819.2M
Revenue:
--
EPS (TTM):
-$1.32
Earnings Data
Next earnings date for DRUG.CX
Dec 24
2025
Most recent earnings per share
-$0.74
Beat by $0.14
(Aug 14/2025)
Consensus Estimate
-$0.88
(Aug 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DRUG.CX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2025 | Q4 | -- | -- | -- | -$1.21 | -- |
| 12/24/2025 | Q3 | -- | -- | -- | -$1.00 | -- |
| 08/14/2025 | Q2 | -- | -- | -$0.74 | -$0.88 | $0.14 |
| 05/15/2025 | Q1 | -- | -- | -$0.42 | -$0.46 | $0.04 |
| 02/13/2025 | Q4 | -- | -- | $0.01 | -$0.50 | $0.51 |
| 09/30/2024 | Q3 | -- | -- | -$0.17 | -$0.60 | $0.43 |
| 06/30/2024 | Q2 | -- | -- | $0.05 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.13 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.44 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.41 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.39 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.54 | -- | -- |
| 02/14/2023 | Q4 | -- | -- | -$0.65 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.99 | -- | -- |
| 08/30/2022 | Q2 | -- | -- | -$1.12 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$1.89 | -- | -- |
| 02/14/2022 | Q4 | -- | -- | -$2.05 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$1.21 | -- | -- |
| 08/30/2021 | Q2 | -- | -- | -$1.49 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.81 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.59 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.31 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.03 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.02 | -- | -- |
Bright Minds Biosciences, Inc. Earnings Questions
-
How Much did Bright Minds Biosciences, Inc. Generate in Revenue Last Quarter?
Bright Minds Biosciences, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Bright Minds Biosciences, Inc. Beat Earnings Last Quarter?
Bright Minds Biosciences, Inc. announced earnings per share of -$0.74 which represents a beat of analyst forecast a -$0.88 per share.
-
Is Bright Minds Biosciences, Inc. Profitable?
Bright Minds Biosciences, Inc. reported -$15.8K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Bright Minds Biosciences, Inc. EPS Next Year?
Bright Minds Biosciences, Inc.'s earnings are forecast to decrease from -$0.65 per share to -$2.30 per share next year representing a decrease of -960.99%.
-
When is Bright Minds Biosciences, Inc.'s Earnings Date?
Currently, Bright Minds Biosciences, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 25, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 3.18% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 1.39% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.67% over the past day.
